Tech Entrepreneur Bryan Johnson Diagnosed With Autoimmune Gastritis After Years Undetected

Bryan Johnson, the tech entrepreneur known for his obsessive approach to longevity, discovered something unsettling during a routine medical checkup: his own immune system had been quietly dismantling his stomach lining for more than a decade. He felt fine. By every conventional measure, he was healthy. Yet biopsies taken during an upper endoscopy revealed early autoimmune gastritis—a condition in which the body's defenses attack the parietal cells that line the stomach and produce both acid and the intrinsic factor needed to absorb vitamin B12 and iron. Johnson shared the diagnosis publicly on X, along with images from his endoscopy, framing it as a cautionary tale about the gap between feeling well and actually being well.

Autoimmune gastritis, also called autoimmune atrophic gastritis, is far more common than most people realize. Between 2 and 5 percent of the population carries the condition, though the true figure may be higher because it hides so effectively. One study found that 18 percent of people with precancerous stomach lesions carried the antibodies associated with the disease, yet only 1 percent had ever received a diagnosis. The condition strikes women more often than men and frequently appears alongside other autoimmune disorders. Johnson's case also reflected what doctors call thyrogastric syndrome—a documented link between autoimmune thyroid disease and gastritis. He had been diagnosed with hypothyroidism at age 21 and had been on thyroid replacement therapy ever since.

The disease works by degrees. Early warning signs often go unrecognized because they mimic common nutritional problems. Iron deficiency is typically the first signal, but it can be easy to dismiss if hemoglobin and hematocrit levels stay within normal ranges. Later, vitamin B12 deficiency emerges, which can trigger neurological damage if left unchecked. Over time, the condition increases the risk of gastric cancer. For Johnson, the key clue was persistently low ferritin—the protein that stores iron—that refused to budge despite eleven years of dietary adjustments, supplements, and every oral iron treatment available. Doctor after doctor had shrugged it off because his standard blood work looked fine.

Johnson traced the possible roots of his condition backward through his own history. His childhood diet consisted largely of sugary cereals, soft drinks, and fast food. As a young adult building a business and raising three children, he endured years of chronic stress. During that period he gained forty pounds and struggled with depression. Whether any of these factors directly triggered the autoimmune response remains unclear, but the timeline is there.

The breakthrough came only after his doctors found anti-parietal cell antibodies at five times the normal limit—a finding that finally prompted an upper endoscopy rather than the colonoscopy that had previously found nothing amiss. The biopsies told the story: atrophy in the acid-producing regions of his stomach lining, no H. pylori infection, no polyps or cancer. Just years of silent cellular damage.

Johnson's case illustrates a broader problem in medicine: the assumption that absence of symptoms equals absence of disease. Routine screening caught what he felt nothing. The condition he carries will require lifelong monitoring and likely vitamin B12 supplementation to prevent neurological complications. But the larger point he seems intent on making is that feeling exceptional—which by most accounts he does—is not the same as being disease-free. Proactive testing, not just reactive medicine, is what finally revealed what his body had been doing to itself all along.